Second quarter revenues increased 4% to $3.48 million; second quarter gross margin was 46.6% versus 46.2% Second quarter net income increased 50% to $178,000 First half FY2021 sales of $6.9 million increased 12% year-over-year; net income of $346,000, more than doubled from the $140,000 reported in the prior year period… Read More..

SOUTH ORANGE, NJ, Oct. 16, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH) (“Nephros” or the “Company”), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical device and commercial markets, today announced the pricing of a registered direct offering of 833,333… Read More..

A series of clinical case reports and animal studies support the broad potential of AC5 Advanced Wound System in a range of complicated acute and chronic wounds FRAMINGHAM, Mass., Oct. 14, 2020 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) (“Arch” or the “Company”), developer of novel liquid, gel and solid… Read More..